E88.3Billable
Tumor lysis syndrome
Chapter 4: Endocrine, nutritional and metabolic diseases
Inclusion Terms
2 items
Inclusion Terms
- •Tumor lysis syndrome (spontaneous)
- •Tumor lysis syndrome following antineoplastic drug chemotherapy
Use Additional Code
1 item
Use Additional Code
- •code for adverse effect, if applicable, to identify drug (T45.1X5)
Billable Code
E88.3 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
Additional Information from Parent Codes
The following information may apply to this code from its parent codes in the ICD-10 hierarchy. This information is important for proper coding and classification.
Parent Codes Referenced:
Excludes1
2 items
Excludes1
From E00-E89:
- •transitory endocrine and metabolic disorders specific to newborn (P70-P74)
Use Additional Code
1 item
Use Additional Code
From E88:
- •codes for associated conditions
Notes
1 item
Notes
From E00-E89:
- •All neoplasms, whether functionally active or not, are classified in Chapter 2. Appropriate codes in this chapter (i.e. E05.8, E07.0, E16-E31, E34.-) may be used as additional codes to indicate either functional activity by neoplasms and ectopic endocrine tissue or hyperfunction and hypofunction of endocrine glands associated with neoplasms and other conditions classified elsewhere.